Simris Group AB Sustainability Reports
Simris Group AB is a biotechnology company that researches, develops, and produces bioactive substances from microalgae and cyanobacteria. The company specializes in the development of next-generation antibody-drug conjugate (ADC) payloads for cancer treatment.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 529900P0ACIS2UI3ZX27
FIGI: BBG006XVNTC9
1 reports from 2022 to 2022